Skip to main content
. 2015 Aug 10;70(1):97–103. doi: 10.1136/jech-2015-205738

Table 2.

Comparisons of ACEI dispensation between groups

ACEI dispensation ≤1 year of hospitalisation for HF (%) p Value
Sex, n=93 258 <0.001
 Women 47.1
 Men 55.5
Age class (years), n=93 258 <0.001
 20–64 69.4
 65–74 60.9
 75–84 53.3
 ≥85 40.3
Country/region of birth, n=93 243 <0.001
 Sweden 50.9
 Nordic country 55.9
 EU 27* 53.4
 Other European countries+Former Soviet 58.2
 Asia+Oceania 60.9
 Other 56.3
Educational level, n=87 644 <0.001
 <9 years of compulsory school 50.8
 9 years of compulsory school 55.8
 ≤2 years of upper secondary school 53.7
 3 years of upper secondary school 54.2
 <3 years of higher education 55.0
 ≥3 years of higher education 54.9
Employment status, n=91 373 <0.001
 Gainfully employed 73.0
 Sporadic gainful employment 58.0
 No gainful employment 50.1
Income class (quartiles), n=91 373 <0.001
 ≤€11 884 51.1
 €11 895–€14 222 50.0
 €14 233–€18 083 51.9
 ≥€18 083 55.3

*EU 27=Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, The Netherlands, Portugal, Spain, UK, Austria, Finland, Sweden, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Slovakia, Slovenia, Bulgaria, Romania.

ACEI, ACE inhibitor; HF, heart failure.